Skip to content

Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

Augustus John Rush, Madhukar H. Trivedi, Stephen R. Wisniewski, Andrew Alan Nierenberg, Jonathan W. Stewart, Diane Warden, George Niederehe, Michael E. Thase, Philip William Lavori, Barry D. Lebowitz, Patrick J. McGrath, Jerrold F. Rosenbaum, Harold A. Sackeïm, David J. Kupfer, James F. Luther, Maurizio Fava M. D

American Journal of Psychiatry · 2006 · 6,027 citations

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., McGrath, P. J., Rosenbaum, J. F., Sackeïm, H. A., Kupfer, D. J., Luther, J. F., & D, M. F. M. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163(11), 1905. https://doi.org/10.1176/ajp.2006.163.11.1905

In text: (Rush et al., 2006)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

OBJECTIVE: This report describes the participants and compares the acute and longer-term treatment outcomes associated with each of four successive steps in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. METHOD: A broadly representative adult outpatient sample with nonpsychotic major depressive disorder received one (N=3,671) to four (N=123) successive acute treatment steps. Those not achieving remission with or unable to tolerate a treatment step were encouraged to move to the next step. Those with an acceptable benefit, preferably symptom remission, from any particular step could enter a 12-month naturalistic follow-up phase. A score of <or=5 on the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR(16)) (equivalent to <or=7 on the 17-item Hamilton Rating Scale for Depression [HRSD(17)]) defined remission; a QIDS-SR(16) total score of >or=11 (HRSD(17)>or=14) defined relapse. RESULTS: The QIDS-SR(16) remission rates were 36.8%, 30.6%, 13.7%, and 13.0% for the first, second, third, and fourth acute treatment steps, respectively. The overall cumulative remission rate was 67%. Overall, those who required more treatment steps had higher relapse rates during the naturalistic follow-up phase. In addition, lower relapse rates were found among participants who were in remission at follow-up entry than for those who were not after the first three treatment steps. CONCLUSIONS: When more treatment steps are required, lower acute remission rates (especially in the third and fourth treatment steps) and higher relapse rates during the follow-up phase are to be expected. Studies to identify the best multistep treatment sequences for individual patients and the development of more broadly effective treatments are needed.

  1. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research.1991
  2. The necessary and sufficient conditions of therapeutic personality change.1957
  3. Emotional processing of fear: Exposure to corrective information.1986
  4. Mindfulness Training as a Clinical Intervention: A Conceptual and Empirical Review2003
  5. The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review.2010

Metadata from OpenAlex (CC0). Citations are generated from the published record.